Wilson's disease. Update of a systemic disorder with protean manifestations.
暂无分享,去创建一个
[1] A. Aisen,et al. Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients. , 1994, Archives of neurology.
[2] J M Walshe,et al. Wilson's disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven patients. , 1989, The Quarterly journal of medicine.
[3] J. Ironside,et al. An unusual case of Wilson's disease. , 1985, The Quarterly journal of medicine.
[4] Stephan Nussberger,et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter , 1997, Nature.
[5] Jingshi Wu,et al. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene , 1994, Nature Genetics.
[6] B. Walia,et al. Fulminant hepatic failure and acute intravascular haemolysis as presenting manifestations of Wilson's disease in young children , 1992, Journal of gastroenterology and hepatology.
[7] B. Portmann,et al. Fulminant hepatic failure resulting from coexistent Wilson's disease and hepatitis E. , 1994, Gut.
[8] R. Willson,et al. Unmeasurable serum alkaline phosphatase activity in wilson's disease associated with fulminant hepatic failure and hemolysis , 1987, Hepatology.
[9] E. Dickson,et al. Pigmented corneal rings in non-Wilsonian liver disease. , 1977, Annals of internal medicine.
[10] J. Cuthbert. Iron, HFE, and hemochromatosis update. , 1997, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[11] U. Landegren,et al. Efficient detection of mutations in Wilson disease by manifold sequencing. , 1996, Genomics.
[12] J. Gitlin,et al. Expression of the Wilson disease gene is deficient in the Long-Evans Cinnamon rat. , 1994, The Biochemical journal.
[13] D. Carnes,et al. Hypoparathyroidism in Wilson's disease. , 1983, The New England journal of medicine.
[14] J. Peppercorn,et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene , 1993, Nature Genetics.
[15] L. Cavalli-Sforza,et al. Wilson's disease in Israel: a genetic and epidemiological study , 1990, Annals of human genetics.
[16] T. Dening,et al. Wilson's disease. Psychiatric symptoms in 195 cases. , 1989, Archives of general psychiatry.
[17] B. Hoppe,et al. Hypercalciuria and Nephrocalcinosis, a Feature of Wilson’s Disease , 1993 .
[18] C. Datz,et al. Detection of the His1069Gln Mutation in Wilson Disease by Rapid Polymerase Chain Reaction , 1997, Annals of Internal Medicine.
[19] I. Sternlieb,et al. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease. , 1987, New England Journal of Medicine.
[20] J. Mason,et al. The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy. , 1992, The Journal of laboratory and clinical medicine.
[21] J. Walshe,et al. Chelation treatment of neurological Wilson's disease. , 1993, The Quarterly journal of medicine.
[22] I. Sternlieb,et al. Morphologic and chemical studies on a murine mutation (toxic milk mice) resulting in hepatic copper toxicosis. , 1988, Laboratory investigation; a journal of technical methods and pathology.
[23] E. Cauza,et al. Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin. , 1997, Journal of hepatology.
[24] N. Takeichi,et al. Prevention of spontaneous hepatocellular carcinoma in long‐evans cinnamon rats with hereditary hepatitis by th administration of d‐penicillamine , 1993, Hepatology.
[25] R. Hu. Severe spinal degeneration in Wilson's disease. , 1994, Spine.
[26] S. Virgiliis,et al. Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations. , 1995, American journal of human genetics.
[27] D. Frommer. Urinary copper excretion and hepatic copper concentrations in liver disease. , 1981, Digestion.
[28] A. Schäffer,et al. Biochemistry of metallothionein. , 1988, Biochemistry.
[29] I. Sternlieb,et al. The role of radiocopper in the diagnosis of Wilson's disease. , 1979, Gastroenterology.
[30] D W Cox,et al. The toxic milk mouse is a murine model of Wilson disease. , 1996, Human molecular genetics.
[31] J. Polio,et al. Hepatocellular Carcinoma in Wilson's Disease Case Report and Review of the Literature , 1989, Journal of clinical gastroenterology.
[32] H. Schumacher,et al. The arthropathy of Wilson's disease: clinical and pathologic features. , 1988, The Journal of rheumatology.
[33] E. Dickson,et al. Diagnosis of Wilson's disease presenting as fulminant hepatic failure. , 1983, Gastroenterology.
[34] J. Valentine,et al. BIOCHEMISTRY: Delivering Copper Inside Yeast and Human Cells , 1997 .
[35] K. Ishak,et al. Histology of the liver in Wilson's disease: a study of 34 cases. , 1980, American journal of clinical pathology.
[36] Y. Shoenfeld,et al. Acute varicella infection heralding Wilsonian crisis. , 1994, Journal of clinical gastroenterology.
[37] R. Klausner,et al. Biochemical Characterization of the Wilson Disease Protein and Functional Expression in the Yeast Saccharomyces cerevisiae * , 1997, The Journal of Biological Chemistry.
[38] R. Klausner,et al. Identification and Functional Expression of HAH1, a Novel Human Gene Involved in Copper Homeostasis* , 1997, The Journal of Biological Chemistry.
[39] P. Lockhart,et al. Ligand‐regulated transport of the Menkes copper P‐type ATPase efflux pump from the Golgi apparatus to the plasma membrane: a novel mechanism of regulated trafficking. , 1996, The EMBO journal.
[40] D. Danks. Disorders of copper transport , 1989 .
[41] Burton Combes,et al. Low serum alkaline phosphatase activity in Wilson's disease , 1986, Hepatology.
[42] J. Walshe. TREATMENT OF WILSON'S DISEASE WITH TRIENTINE (TRIETHYLENE TETRAMINE) DIHYDROCHLORIDE , 1982, The Lancet.
[43] M. Sato,et al. Inhibition of the copper incorporation into ceruloplasmin leads to the deficiency in serum ceruloplasmin activity in Long-Evans cinnamon mutant rat. , 1993, The Journal of biological chemistry.
[44] T. Gilliam,et al. Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. , 1997, American journal of human genetics.
[45] E. D. Harris. Copper Transport: An Overview , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[46] Hogland Hc,et al. Hematologic (cytopenic) manifestations of Wilson's disease (hepatolenticular degeneration). , 1978 .
[47] J. Lau,et al. Wilson's disease: 35 years' experience. , 1990, The Quarterly journal of medicine.
[48] P. Wong,et al. Primary hepatocellular carcinoma associated with Wilson's disease in a young woman. , 1985, Postgraduate medical journal.
[49] E. Stewart,et al. Polymorphic microsatellites and Wilson disease (WD). , 1993, American journal of human genetics.
[50] M. Frydman,et al. Endocrine studies of the ovulatory disturbances in Wilson’s disease (hepatolenticular degeneration) , 1987 .
[51] Scheinberg Ih. Wilson's disease. , 1981 .
[52] I. Sternlieb,et al. Pleiotropic effect of LEC mutation: a rodent model of Wilson's disease. , 1993, The American journal of physiology.
[53] D. Watkin,et al. REHABILITATION IN SCHIZOPHRENIA. , 1965, Lancet.
[54] J. Cuthbert,et al. Wilson's disease: a new gene and an animal model for an old disease. , 1995, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[55] T. Gilliam,et al. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. , 1994, Human molecular genetics.
[56] I. Sternlieb,et al. Is non-Indian childhood cirrhosis caused by excess dietary copper? , 1994, The Lancet.
[57] J. Walshe,et al. Wilson's disease: the problem of delayed diagnosis. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[58] D. Cox,et al. The Wilson disease gene: spectrum of mutations and their consequences , 1995, Nature Genetics.
[59] J. Valentine,et al. Delivering Copper Inside Yeast and Human Cells , 1997, Science.
[60] B. Portmann,et al. Hepatic morphology and histochemistry of Wilson's disease presenting as fulminant hepatic failure: a study of 11 cases , 1989, Histopathology.
[61] T. Lyon,et al. Copper associated childhood cirrhosis. , 1994, Gut.
[62] N. Chu,et al. Geographic variations in Wilson's disease , 1993, Journal of the Neurological Sciences.
[63] Shin Lin,et al. Metal ion chaperone function of the soluble Cu(I) receptor Atx1. , 1997, Science.
[64] R. Steinert,et al. Pseudo-Kayser-Fleischer ring of the cornea associated with non-Wilsonian liver disease. A case report and literature review. , 1993, Cornea.
[65] J. Rommens,et al. The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene , 1993, Nature Genetics.
[66] M. Akil,et al. The psychiatric presentations of Wilson's disease. , 1991 .
[67] J. Gitlin,et al. Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. , 1996, Human molecular genetics.
[68] J. Walshe,et al. DIAGNOSIS AND TREATMENT OF PRESYMPTOMATIC WILSON'S DISEASE , 1988, The Lancet.
[69] J. Willeit,et al. Copper-induced acute rhabdomyolysis in Wilson's disease. , 1995, Gastroenterology.
[70] D. Glerum,et al. Isolation of a cDNA encoding the human homolog of COX17, a yeast gene essential for mitochondrial copper recruitment , 1997, Human Genetics.
[71] D. Danks,et al. Wilson's disease in adults with cirrhosis but no neurological abnormalities. , 1990, BMJ.
[72] Bing Zhou,et al. hCTR1: a human gene for copper uptake identified by complementation in yeast. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[73] M. Frydman. Genetic aspects of Wilson's disease , 1990, Journal of gastroenterology and hepatology.
[74] J. Gitlin,et al. Biochemical characterization and intracellular localization of the Menkes disease protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[75] P. Kuan. Cardiac Wilson's disease. , 1987, Chest.
[76] G. Brewer,et al. Diagnosis and characterization of presymptomatic patients with Wilson's disease and the use of molecular genetics to aid in the diagnosis. , 1991, The Journal of laboratory and clinical medicine.
[77] A. Giagheddu,et al. Epidemiologic study of hepatolenticular degeneration (Wilson's disease) in Sardinia (1902–1983) , 1985, Acta neurologica Scandinavica.
[78] J. Juyn,et al. H714Q mutation in Wilson disease is associated with late, neurological presentation. , 1995, Journal of medical genetics.
[79] R. Casareno,et al. The Copper Chaperone for Superoxide Dismutase* , 1997, The Journal of Biological Chemistry.
[80] I. Sternlieb,et al. Liver transplantation for Wilson's disease: Indications and outcome , 1994, Hepatology.
[81] B. Combes,et al. DETECTION OF THE HETEROZYGOUS CARRIER OF THE WILSON'S DISEASE GENE. , 1961, The Journal of clinical investigation.
[82] H. Cheong,et al. Recurrent Hypokalemic Muscle Weakness as an Initial Manifestation of Wilson’s Disease , 1996 .
[83] R. Calne,et al. Reversal of severe neurological manifestations of Wilson's disease following orthotopic liver transplantation. , 1987, The Quarterly journal of medicine.
[84] Y. Niitsu,et al. Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans Cinnamon rats. , 1996, The Journal of clinical investigation.
[85] M. Suzuki,et al. Impaired Hepatic Copper Homeostasis in Long-Evans Cinnamon Rats: Reduced Biliary Excretion of Copper , 1994, Pediatric Research.
[86] R. Williams,et al. Wilson's disease: clinical presentation and use of prognostic index. , 1986, Gut.
[87] S. Packman,et al. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper–transporting ATPase , 1993, Nature Genetics.
[88] J. Gitlin,et al. Functional Expression of the Menkes Disease Protein Reveals Common Biochemical Mechanisms Among the Copper-transporting P-type ATPases* , 1998, The Journal of Biological Chemistry.
[89] N. A. Holtzman,et al. Studies on the rate of release and turnover of ceruloplasmin and apoceruloplasmin in rat plasma. , 1970, The Journal of biological chemistry.
[90] Akinori Nakamura,et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans , 1995, Nature Genetics.
[91] A. Odermatt,et al. Copper pumping ATPases: Common concepts in bacteria and man , 1994, FEBS letters.
[92] L. Deecke,et al. Wilson's disease , 1993, Neurology.
[93] G. Mieli-Vergani,et al. Failure of simple biochemical indexes to reliably differentiate fulminant wilson's disease from other causes of fulminant liver failure , 1992, Hepatology.
[94] J. Walshe,et al. Liver copper concentration in Wilson‘s disease: Effect of treatment with ‘anti‐copper’ agents , 1990, Journal of gastroenterology and hepatology.
[95] S. Govindarajan,et al. Hepatocellular carcinoma in a case of Wilson's disease. , 2008, Liver.
[96] R. MacGillivray,et al. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[97] H. Rauch. Toxic milk, a new mutation affecting cooper metabolism in the mouse. , 1983, The Journal of heredity.
[98] S. Sherlock,et al. Histological demonstration of copper and copper-associated protein in chronic liver diseases. , 1978, Journal of clinical pathology.
[99] T. Sugimura,et al. Inhibition of hereditary hepatitis and liver tumor development in Long‐Evans cinnamon rats by the copper‐chelating agent trientine dihydrochloride , 1996, Hepatology.
[100] J. Walshe,et al. Copper: Its Role in the Pathogenesis of Liver Disease , 1984, Seminars in liver disease.
[101] Ø. Aagenæs. HEREDITARY RECURRENT CHOLESTASIS WITH LYMPHOEDEMA–TWO NEW FAMILIES , 1974 .
[102] S. Nakada,et al. Wilson's disease presenting as symptomatic urolithiasis: a case report and review of the literature. , 1994, The Journal of urology.
[103] Y. Li,et al. Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. A model of Wilson's disease. , 1991, The Journal of clinical investigation.
[104] A. Członkowska,et al. Late onset of Wilson's disease. Report of a family. , 1981, Archives of neurology.
[105] W. Gahl,et al. Indian childhood cirrhosis in an American child. , 1992, Gastroenterology.
[106] M. Mori,et al. The LEC rat: a model for human hepatitis, liver cancer, and much more. , 1994, The American journal of pathology.
[107] J. Roh,et al. Initial and follow‐up brain MRI findings and correlation with the clinical course in Wilson's disease , 1994, Neurology.
[108] C. Seymour,et al. Defective biliary copper excretion in Wilson's disease: the role of caeruloplasmin , 1996, European journal of clinical investigation.
[109] R. Palmiter,et al. A murine model of Menkes disease reveals a physiological function of metallothionein , 1996, Nature Genetics.
[110] K. Schärer,et al. Proteinuria and other renal functions in Wilson’s disease , 1997, Pediatric Nephrology.
[111] J. Walshe. The management of pregnancy in Wilson's disease treated with trientine. , 1986, The Quarterly journal of medicine.
[112] M. Schilsky. Wilson Disease: Genetic Basis of Copper Toxicity and Natural History , 1996, Seminars in liver disease.
[113] D. V. van Thiel,et al. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. , 1991, Gastroenterology.
[114] H. Wahner,et al. Wilson's disease (hepatolenticular degeneration) of late adult onset: report of case. , 1975, Mayo Clinic proceedings.